User profiles for Gabriela Chiosis

Gabriela Chiosis

Professor, Memorial Sloan Kettering
Verified email at mskcc.org
Cited by 17115

[HTML][HTML] A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast …

G Chiosis, MN Timaul, B Lucas, PN Munster… - Chemistry & biology, 2001 - cell.com
Background: The Hsp90s contain a conserved pocket that binds ATP/ADP and plays an
important role in the regulation of chaperone function. Occupancy of this pocket by several …

[HTML][HTML] Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function

AD Basso, DB Solit, G Chiosis, B Giri, P Tsichlis… - Journal of Biological …, 2002 - ASBMB
Hsp90 is a chaperone required for the conformational maturation of certain signaling proteins
including Raf, cdk4, and steroid receptors. Natural products and synthetic small molecules …

[HTML][HTML] Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers

K Jhaveri, T Taldone, S Modi, G Chiosis - Biochimica et Biophysica Acta …, 2012 - Elsevier
Hsp90 is an ATP dependent molecular chaperone protein which integrates multiple
oncogenic pathways. As such, Hsp90 inhibition is a promising anti-cancer strategy. Several …

Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90

…, SD Nimer, A Melnick, L Neckers, G Chiosis - Nature chemical …, 2011 - nature.com
Most cancers are characterized by multiple molecular alterations, but identification of the key
proteins involved in these signaling pathways is currently beyond reach. We show that the …

Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

…, A Goel, M Gönen, Z Estrov, BL Ebert, G Chiosis… - Nature, 2012 - nature.com
The identification of somatic activating mutations in JAK2 (refs 1 ) and in the thrombopoietin
receptor gene (MPL) 5 in most patients with myeloproliferative neoplasm (MPN) led to the …

[PDF][PDF] Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators

…, SM Raj, KN Maloney, J Clardy, WC Hahn, G Chiosis… - Cancer cell, 2006 - cell.com
Although androgen receptor (AR)-mediated signaling is central to prostate cancer, the ability
to modulate AR signaling states is limited. Here we establish a chemical genomic approach …

The epichaperome is an integrated chaperome network that facilitates tumour survival

…, SM Larson, JS Lewis, ML Guzman, G Chiosis - Nature, 2016 - nature.com
Transient, multi-protein complexes are important facilitators of cellular functions. This
includes the chaperome, an abundant protein family comprising chaperones, co-chaperones, …

New arylthioindoles: Potent Inhibitors of tubulin polymerization. 2. Structure− activity relationships and molecular modeling studies

…, D Barrow, RI Nicholson, G Chiosis… - Journal of medicinal …, 2006 - ACS Publications
Arylthioindoles (ATIs) that possess a 3-methoxyphenylthio or a 3,5-dimethoxyphenylthio
moiety at position 2 of the indole ring were effective tubulin assembly inhibitors, but weak …

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

…, L Varticovski, A Melnick, G Chiosis - Proceedings of the …, 2009 - National Acad Sciences
Triple-negative breast cancers (TNBCs) are defined by a lack of expression of estrogen,
progesterone, and HER2 receptors. Because of the absence of identified targets and targeted …

Targeting Hsp90: small-molecule inhibitors and their clinical development

T Taldone, A Gozman, R Maharaj, G Chiosis - Current opinion in …, 2008 - Elsevier
The Hsp90 multichaperone complex has important roles in the development and progression
of malignant transformation. Several small-molecule inhibitors of Hsp90 of diverse …